Gene · 2877
Papers1,817
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
141 to 160 of 1,817
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Thioredoxin/Glutaredoxin Systems and Gut Microbiota in NAFLD: Interplay, Mechanism, and Therapeutical Potential. | Antioxidants (Basel) | 2023 | 37759983 | PubTator, text mining | PubMed |
| ACVRL1 drives resistance to multitarget tyrosine kinase inhibitors in colorectal cancer by promoting USP15-mediated GPX2 stabilization. | BMC Med | 2023 | 37743483 | PubTator, text mining | PubMed |
| Infection and inflammation stimulate expansion of a CD74+ Paneth cell subset to regulate disease progression. | EMBO J | 2023 | 37718683 | PubTator, text mining | PubMed |
| Sulforaphane rewires central metabolism to support antioxidant response and achieve glucose homeostasis. | Redox Biol | 2023 | 37703668 | PubTator, text mining | PubMed |
| Characterization of chemoresistant human non-small cell lung cancer cells by metabolic and lipidomic profiling. | Metabolomics | 2023 | 37690093 | PubTator, text mining | PubMed |
| Identification of molecular subgroups and establishment of risk model based on the response to oxidative stress to predict overall survival of patients with lung adenocarcinoma. | Eur J Med Res | 2023 | 37689745 | PubTator, text mining | PubMed |
| Rapid Chemical Profiling of Filipendula ulmaria Using CPC Fractionation, 2-D Mapping of 13C NMR Data, and High-Resolution LC-MS. | Molecules | 2023 | 37687176 | PubTator, text mining | PubMed |
| Lineage Plasticity and Stemness Phenotypes in Prostate Cancer: Harnessing the Power of Integrated "Omics" Approaches to Explore Measurable Metrics. | Cancers (Basel) | 2023 | 37686633 | PubTator, text mining | PubMed |
| Reactive Oxygen Species: A Crosslink between Plant and Human Eukaryotic Cell Systems. | Int J Mol Sci | 2023 | 37685857 | PubTator, text mining | PubMed |
| Changes in m6A RNA methylation of goat lung following PPRV infection. | Heliyon | 2023 | 37681172 | PubTator, text mining | PubMed |
| A new NRF2 activator for the treatment of human metabolic dysfunction-associated fatty liver disease. | JHEP Rep | 2023 | 37663119 | PubTator, text mining | PubMed |
| Dysregulated anti-oxidant signalling and compromised mitochondrial integrity negatively influence regulatory T cell function and viability in liver disease. | EBioMedicine | 2023 | 37657135 | PubTator, text mining | PubMed |
| Lipid peroxidation in osteoarthritis: focusing on 4-hydroxynonenal, malondialdehyde, and ferroptosis. | Cell Death Discov | 2023 | 37644030 | PubTator, text mining | PubMed |
| Targeting drug-tolerant cells: A promising strategy for overcoming acquired drug resistance in cancer cells. | MedComm (2020) | 2023 | 37638338 | PubTator, text mining | PubMed |
| Cellular heterogeneity and plasticity during NAFLD progression. | Front Mol Biosci | 2023 | 37635938 | PubTator, text mining | PubMed |
| FSP1 confers ferroptosis resistance in KEAP1 mutant non-small cell lung carcinoma in NRF2-dependent and -independent manner. | Cell Death Dis | 2023 | 37633973 | PubTator, text mining | PubMed |
| Potential Use of Antioxidant Compounds for the Treatment of Inflammatory Bowel Disease. | Pharmaceuticals (Basel) | 2023 | 37631065 | PubTator, text mining | PubMed |
| The Post-Translational Modifications of Human Salivary Peptides and Proteins Evidenced by Top-Down Platforms. | Int J Mol Sci | 2023 | 37628956 | PubTator, text mining | PubMed |
| Proteomics of adjacent-to-tumor samples uncovers clinically relevant biological events in hepatocellular carcinoma. | Natl Sci Rev | 2023 | 37575948 | PubTator, text mining | PubMed |
| Establishment of a prognostic model toward lung squamous cell carcinoma based on m7G-related genes in the cancer genome atlas. | Physiol Genomics | 2023 | 37575065 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/2877/papers?page=8